Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 HKD | +5.00% |
|
+1.94% | -53.95% |
Jun. 10 | Brii Biosciences Presents Hepatitis B Drug Data at European Medical Conference | MT |
Jun. 07 | Brii Biosciences Limited Announces New Data from Two Phase 2 Studies Evaluating BRII-179 | CI |
Business Summary
Number of employees: 128
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies for Infectious Diseases and Central Nervous System Diseases
100.0
%
| 60 | 100.0 % | 1 | 100.0 % | -98.86% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 60 | 100.0 % | 1 | 100.0 % | -98.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Hong
CEO | Chief Executive Officer | 60 | 17-12-07 |
An Kang Li
DFI | Director of Finance/CFO | 47 | 20-08-31 |
David Margolis
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yao Zhang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Qing Zhu
CTO | Chief Tech/Sci/R&D Officer | 57 | 18-04-01 |
Eleanor de Groot
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-08-14 |
Chris Fang
IRC | Investor Relations Contact | - | - |
Human Resources Officer | 49 | 22-01-26 | |
Corporate Officer/Principal | 62 | 18-03-11 | |
Corporate Officer/Principal | 57 | 18-03-18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 21-06-21 |
Tai Yin Yang
BRD | Director/Board Member | 70 | 22-08-31 |
Robert Nelsen
BRD | Director/Board Member | 60 | 18-06-21 |
Martin Murphy
BRD | Director/Board Member | 81 | 21-06-21 |
Yiu Wa Tsui
BRD | Director/Board Member | 74 | 21-06-21 |
Zhi Hong
CEO | Chief Executive Officer | 60 | 17-12-07 |
Hui Tang
BRD | Director/Board Member | 64 | 21-06-21 |
An Kang Li
DFI | Director of Finance/CFO | 47 | 20-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 729,989,776 | 587,749,041 ( 80.51 %) | 0 | 80.51 % |
Company contact information
Brii Biosciences Ltd. (China)
Zhongguancun Dongsheng, Building 7 1 North Yongtaizhuang Road
100192, Haidian
+
http://www.briibio.com![address Brii Biosciences Limited(2137)](https://cdn.zonebourse.com/static/address/124598684.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.95% | 98.16M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- 2137 Stock
- Company Brii Biosciences Limited